Description

BSE circular containing clarifications from DOLAT ALGOTECH LIMITED, Eris Lifesciences Limited, and INOX Green Energy Services Limited regarding significant increase in share trading volumes.

Summary

BSE sought clarifications from DOLAT ALGOTECH LIMITED (scrip code: 505526), Eris Lifesciences Limited (security code: 540596), and INOX Green Energy Services Limited regarding significant increases in their share trading volumes on December 10, 2025. All three companies confirmed that they have disclosed all material information in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and that the volume increases are purely market-driven with no undisclosed developments.

Key Points

  • DOLAT ALGOTECH LIMITED confirmed all material information has been duly disclosed to stock exchanges
  • Eris Lifesciences stated that all necessary disclosures under Regulation 30 and insider trading regulations have been made within stipulated time
  • All three companies confirmed no pending information or announcements that could explain the volume increase
  • Companies attributed volume increases to market conditions and market-driven activity
  • No company involvement or connection with the volume increases was reported

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Companies are required to respond to BSE surveillance queries regarding unusual trading activity
  • Companies must confirm compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Companies must disclose if there is any undisclosed material information affecting trading activity

Important Dates

  • December 10, 2025: Date of BSE surveillance email and company responses

Impact Assessment

This circular has minimal market impact as it represents routine surveillance activity. The clarifications confirm that increased trading volumes are market-driven without any undisclosed material developments. All three companies have maintained compliance with disclosure requirements, providing transparency to market participants. No operational or financial changes were reported that would affect the companies’ business operations or investor decisions.

Impact Justification

Routine clarifications confirming no undisclosed material information; volume increases attributed to market conditions with no regulatory or operational changes.